Inclacumab (Anti-P-Selectin / CD62p)

Synonyms: Anti-Human selectin P Recombinant Antibody

Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.

Inclacumab (Anti-P-Selectin / CD62p)

Purity & Quality Control

≥99

Biological Activity

Description Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.

Product Details

CAS No. 1256258-86-2
Molecular Weight 150
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Inclacumab (Anti-P-Selectin / CD62p) | Inclacumab (Anti-P-Selectin / CD62p) supplier | purchase Inclacumab (Anti-P-Selectin / CD62p) | Inclacumab (Anti-P-Selectin / CD62p) cost | Inclacumab (Anti-P-Selectin / CD62p) manufacturer | order Inclacumab (Anti-P-Selectin / CD62p) | Inclacumab (Anti-P-Selectin / CD62p) distributor